Empirical antimicrobial therapy for bloodstream infections not compliant with guideline was associated with discordant therapy, which predicted poorer outcome even in a low resistance environment.

Autor: Grøv, Kornelius¹ (AUTHOR), Håland, Erling¹ (AUTHOR), Waagsbø, Bjørn² (AUTHOR), Salvesen, Øyvind³ (AUTHOR), Damås, Jan Kristian^3,4,5 (AUTHOR), Afset, Jan Egil^3,5,6 (AUTHOR)

Publikováno v: Infectious Diseases. Dec2022, Vol. 54 Issue 12, p833-845. 13p. 1 Diagram, 4 Charts, 2 Graphs.

HIAD – hydrogen incident and accident database

Autor: Cristina Galassi, M., Papanikolaou, Efthymia, Baraldi, Daniele, Funnemark, Espen, Håland, Erling, Engebø, Angunn, Haugom, Gerd Petra, Jordan, Thomas, Tchouvelev, Andrei V.

Publikováno v: In International Journal of Hydrogen Energy November 2012 37(22):17351-17357

Smac-mimetics reduce numbers and viability of human osteoclasts

Autor: Moen, Ingrid Nyhus, Westhrin, Marita, Håland, Erling, Haug, Markus, Nonstad, Unni, Klaharn, Merisa, Standal, Therese, Starheim, Kristian K.

Externí odkaz: https://hdl.handle.net/11250/2786546

TAK1-inhibitors are cytotoxic for multiple myeloma cells alone and in combination with melphalan.

Autor: Håland E; CEMIR Centre of Molecular Inflammation Research, IKOM, NTNU, Trondheim, Norway.; Department of Clinical and Molecular Medicine, NTNU, Trondheim, Norway., Moen IN; CEMIR Centre of Molecular Inflammation Research, IKOM, NTNU, Trondheim, Norway.; Department of Clinical and Molecular Medicine, NTNU, Trondheim, Norway.; Department of Hematology, St. Olavs University Hospital, Trondheim, Norway., Veidal E; CEMIR Centre of Molecular Inflammation Research, IKOM, NTNU, Trondheim, Norway.; Department of Clinical and Molecular Medicine, NTNU, Trondheim, Norway., Hella H; Department of Clinical and Molecular Medicine, NTNU, Trondheim, Norway., Misund K; Department of Clinical and Molecular Medicine, NTNU, Trondheim, Norway., Slørdahl TS; Department of Clinical and Molecular Medicine, NTNU, Trondheim, Norway.; Department of Hematology, St. Olavs University Hospital, Trondheim, Norway., Starheim KK; CEMIR Centre of Molecular Inflammation Research, IKOM, NTNU, Trondheim, Norway.; Department of Clinical and Molecular Medicine, NTNU, Trondheim, Norway.; Department of Hematology, St. Olavs University Hospital, Trondheim, Norway.

Publikováno v: Oncotarget [Oncotarget] 2021 Oct 12; Vol. 12 (21), pp. 2158-2168. Date of Electronic Publication: 2021 Oct 12 (Print Publication: 2021).